1. Home
  2. ICUCW vs ACGLO Comparison

ICUCW vs ACGLO Comparison

Compare ICUCW & ACGLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SeaStar Medical Holding Corporation Warrant

ICUCW

SeaStar Medical Holding Corporation Warrant

N/A

Current Price

$0.01

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F

ACGLO

Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F

HOLD

Current Price

$21.09

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUCW
ACGLO
Founded
N/A
N/A
Country
United States
Bermuda
Employees
18
5800
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ICUCW
ACGLO
Price
$0.01
$21.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
ICUCW
ACGLO
Relative Strength Index (RSI) 39.35 46.19
Support Level $0.01 $20.96
Resistance Level $0.01 $21.18
Average True Range (ATR) 0.00 0.19
MACD 0.00 0.03
Stochastic Oscillator 70.49 50.72

Price Performance

Historical Comparison
ICUCW
ACGLO

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

Share on Social Networks: